Cargando…
Metformin potentiates rapamycin and cisplatin in gastric cancer in mice
Here we showed that pAMPKα and PTEN were down-regulated and p-mTOR, p-S6, p-4EBP1, MMP7, and DCN1 were up-regulated in human gastric cancer tissue samples as compared to that in the noncancerous tissues. Metformin inhibited tumor growth in mice. Also it enhanced cisplatin- or rapamycin-induced reduc...
Autores principales: | Yu, Yu, Fang, Wenzheng, Xia, Tian, Chen, Ying, Gao, Yunshu, Jiao, Xiaodong, Huang, Suyun, Wang, Jiejun, Li, Zhaosheng, Xie, Keping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494971/ https://www.ncbi.nlm.nih.gov/pubmed/25909163 |
Ejemplares similares
-
PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma
por: Yu, Guanzhen, et al.
Publicado: (2015) -
Towards natural mimetics of metformin and rapamycin
por: Aliper, Alexander, et al.
Publicado: (2017) -
Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways
por: Benedetti, Francesca, et al.
Publicado: (2020) -
Evaluation of Antagonistic Effects of Metformin with Cisplatin in Gastric Cancer Cells
por: Lesan, Vahid, et al.
Publicado: (2014) -
Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice
por: Weiss, Roxanne, et al.
Publicado: (2018)